Search Results 8021-8030 of 28490 for oral

  1. In the Loop: Mayo Nurse Donates Kidney, Gains New Friend

    When Kate Burris sat down to watch an episode of "Grey's Anatomy" last November, the last thing she expected was a life-changing epiphany.

  2. Publications - Nandita Khera, M.D., M.P.H. - Mayo Clinic

    Economic Cost and Sustainability of Oral Therapies in Precision Oncology. JCO Oncol Pract. 2022 Aug; 18 (8):e1247-e1254 Epub 2022 May 26. View PubMed ...

  3. Spinal cord tumor - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  4. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Departments that treat this condition. Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep ...

  5. Parathyroidectomy - Doctors & Departments - Mayo Clinic

    ... Oral surgery, Salivary gland surgery, Throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer ...

  6. Publications - Eric J. Lehrer, M.D. - Mayo Clinic

    ... Oral Tongue. Laryngoscope. 2023 May; 133 (5):1110-1121 Epub 2022 June 18. View PubMed; Lehrer EJ, Ahluwalia MS, Gurewitz J, Bernstein K, Kondziolka D ...

  7. Publications - Reza Arsanjani, M.D. - Mayo Clinic

    Direct oral anticoagulants vs warfarin for atrial fibrillation in patients with transthyretin cardiac amyloidosis: A retrospective cohort analysis. Heart ...

  8. Surgery - Referrals - Mayo Clinic

    Oral and Maxillofacial Surgery Residency, M.D.-O.M.S. (Minnesota) · Orthopedic Sports Medicine Fellowship (Arizona) · Orthopedic Sports Medicine Fellowship ...

  9. Study of INCB053914 in Subjects With Advanced Malignancies - Mayo Clinic

    Unable to swallow and retain oral medication. Unable to comprehend or unwilling to sign the informed consent form (ICF). Any known contraindications to the ...

  10. Hematology - Clinical trials

    Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...